
OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!
If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.
Requested Article:
The m6A Reader YTHDF2 Promotes Bladder Cancer Progression by Suppressing RIG-I–Mediated Immune Response
Lei Zhang, Yuqing Li, Lingli Zhou, et al.
Cancer Research (2023) Vol. 83, Iss. 11, pp. 1834-1850
Open Access | Times Cited: 44
Lei Zhang, Yuqing Li, Lingli Zhou, et al.
Cancer Research (2023) Vol. 83, Iss. 11, pp. 1834-1850
Open Access | Times Cited: 44
Showing 1-25 of 44 citing articles:
The role of m6A methylation in therapy resistance in cancer
Hengzhao Zhuang, Bo Yu, Dan Tao, et al.
Molecular Cancer (2023) Vol. 22, Iss. 1
Open Access | Times Cited: 88
Hengzhao Zhuang, Bo Yu, Dan Tao, et al.
Molecular Cancer (2023) Vol. 22, Iss. 1
Open Access | Times Cited: 88
Crossing epigenetic frontiers: the intersection of novel histone modifications and diseases
Weiyi Yao, Xinting Hu, Xin Wang
Signal Transduction and Targeted Therapy (2024) Vol. 9, Iss. 1
Open Access | Times Cited: 18
Weiyi Yao, Xinting Hu, Xin Wang
Signal Transduction and Targeted Therapy (2024) Vol. 9, Iss. 1
Open Access | Times Cited: 18
Gastric cancer derived exosomal THBS1 enhanced Vγ9Vδ2 T-cell function through activating RIG-I-like receptor signaling pathway in a N6-methyladenosine methylation dependent manner
Juntao Li, Feng Huang, Jinghan Zhu, et al.
Cancer Letters (2023) Vol. 576, pp. 216410-216410
Closed Access | Times Cited: 15
Juntao Li, Feng Huang, Jinghan Zhu, et al.
Cancer Letters (2023) Vol. 576, pp. 216410-216410
Closed Access | Times Cited: 15
Autophagy flux in bladder cancer: Cell death crosstalk, drug and nanotherapeutics
Kuan Liu, Huijing Chen, Yanhong Li, et al.
Cancer Letters (2024) Vol. 591, pp. 216867-216867
Closed Access | Times Cited: 5
Kuan Liu, Huijing Chen, Yanhong Li, et al.
Cancer Letters (2024) Vol. 591, pp. 216867-216867
Closed Access | Times Cited: 5
Specific deletion of Mettl3 in IECs triggers the development of spontaneous colitis and dysbiosis of T lymphocytes in mice
Miao Fang, Jie Yao, Haifeng Zhang, et al.
Clinical & Experimental Immunology (2024) Vol. 217, Iss. 1, pp. 57-77
Closed Access | Times Cited: 4
Miao Fang, Jie Yao, Haifeng Zhang, et al.
Clinical & Experimental Immunology (2024) Vol. 217, Iss. 1, pp. 57-77
Closed Access | Times Cited: 4
Targeting RNA modifications with pharmacological agents: New frontiers in cancer therapy
Angel Guan, Justin Wong
Cancer Medicine (2024) Vol. 13, Iss. 7
Open Access | Times Cited: 4
Angel Guan, Justin Wong
Cancer Medicine (2024) Vol. 13, Iss. 7
Open Access | Times Cited: 4
Clinical Perspectives in Epitranscriptomics
Eloy Santos-Pujol, Carlos Quero-Dotor, Manel Esteller
Current Opinion in Genetics & Development (2024) Vol. 87, pp. 102209-102209
Open Access | Times Cited: 4
Eloy Santos-Pujol, Carlos Quero-Dotor, Manel Esteller
Current Opinion in Genetics & Development (2024) Vol. 87, pp. 102209-102209
Open Access | Times Cited: 4
Loss of YTHDC1 m6A reading function promotes invasiveness in urothelial carcinoma of the bladder
Jinyun Xu, Jonas P. Koch, Claudia Schmidt, et al.
Experimental & Molecular Medicine (2025)
Open Access
Jinyun Xu, Jonas P. Koch, Claudia Schmidt, et al.
Experimental & Molecular Medicine (2025)
Open Access
Unveiling ADAMTS12: A Key Driver of Bladder Cancer Progression via COL3A1-Mediated Activation of the FAK/PI3K/AKT Signaling Pathway
Jianhua Xiao, Li‐zhe Xu, Jinzhuo Ning, et al.
Journal of Biological Chemistry (2025) Vol. 301, Iss. 2, pp. 108155-108155
Closed Access
Jianhua Xiao, Li‐zhe Xu, Jinzhuo Ning, et al.
Journal of Biological Chemistry (2025) Vol. 301, Iss. 2, pp. 108155-108155
Closed Access
Endogenous peptide CBDP1 inhibits clear cell renal cell carcinoma progression by targeting USP5/YTHDF2/TRPM5 axis
Yang Zhang, Wei Zhu, Ruijie Tao, et al.
Journal of Translational Medicine (2025) Vol. 23, Iss. 1
Open Access
Yang Zhang, Wei Zhu, Ruijie Tao, et al.
Journal of Translational Medicine (2025) Vol. 23, Iss. 1
Open Access
Senescence-specific molecular subtypes stratify the hallmarks of the tumor microenvironment and guide precision medicine in bladder cancer
Luzhe Yan, Haisu Liang, Tiezheng Qi, et al.
BMC Cancer (2025) Vol. 25, Iss. 1
Open Access
Luzhe Yan, Haisu Liang, Tiezheng Qi, et al.
BMC Cancer (2025) Vol. 25, Iss. 1
Open Access
YTHDF2 promotes the metastasis of oral squamous cell carcinoma through the JAK-STAT pathway
Zhuo Chen, Dan Zhao, Yamin Yuan, et al.
Scientific Reports (2025) Vol. 15, Iss. 1
Open Access
Zhuo Chen, Dan Zhao, Yamin Yuan, et al.
Scientific Reports (2025) Vol. 15, Iss. 1
Open Access
XIAP promotes metastasis of bladder cancer cells by ubiquitylating YTHDC1
Ning Sun, Sijia Wang, Jianting Liu, et al.
Cell Death and Disease (2025) Vol. 16, Iss. 1
Open Access
Ning Sun, Sijia Wang, Jianting Liu, et al.
Cell Death and Disease (2025) Vol. 16, Iss. 1
Open Access
METTL3 promotes an immunosuppressive microenvironment in bladder cancer via m6A-dependent CXCL5/CCL5 regulation
Yonghua Tong, Zhiqiang Chen, Jian Wu, et al.
Journal for ImmunoTherapy of Cancer (2025) Vol. 13, Iss. 4, pp. e011108-e011108
Open Access
Yonghua Tong, Zhiqiang Chen, Jian Wu, et al.
Journal for ImmunoTherapy of Cancer (2025) Vol. 13, Iss. 4, pp. e011108-e011108
Open Access
CRM1 Mediates the Nuclear Export of YTHDF2
Shumei Wei, Ye Wang, Jiaqi Cao, et al.
Biochemical and Biophysical Research Communications (2025) Vol. 767, pp. 151899-151899
Closed Access
Shumei Wei, Ye Wang, Jiaqi Cao, et al.
Biochemical and Biophysical Research Communications (2025) Vol. 767, pp. 151899-151899
Closed Access
ALYREF m5C RNA methylation reader predicts bladder cancer prognosis by regulating the tumor immune microenvironment
Wen-Gu Pan, Xiaoli Liu, Shuang‐De Liu
Medicine (2024) Vol. 103, Iss. 14, pp. e37590-e37590
Open Access | Times Cited: 3
Wen-Gu Pan, Xiaoli Liu, Shuang‐De Liu
Medicine (2024) Vol. 103, Iss. 14, pp. e37590-e37590
Open Access | Times Cited: 3
Effects and mechanisms of N6-methyladenosine RNA methylation in environmental pollutant-induced carcinogenesis
Tong‐Fei Li, Zhijie Xu, Kui Zhang, et al.
Ecotoxicology and Environmental Safety (2024) Vol. 277, pp. 116372-116372
Open Access | Times Cited: 3
Tong‐Fei Li, Zhijie Xu, Kui Zhang, et al.
Ecotoxicology and Environmental Safety (2024) Vol. 277, pp. 116372-116372
Open Access | Times Cited: 3
Liquid–liquid phase separation in diseases
Xinyue Zhang, Yuan Lin, Wanlu Zhang, et al.
MedComm (2024) Vol. 5, Iss. 7
Open Access | Times Cited: 3
Xinyue Zhang, Yuan Lin, Wanlu Zhang, et al.
MedComm (2024) Vol. 5, Iss. 7
Open Access | Times Cited: 3
FMRP protects breast cancer cells from ferroptosis by promoting SLC7A11 alternative splicing through interacting with hnRNPM
Nan Wang, Bin Shi, Lu Ding, et al.
Redox Biology (2024) Vol. 77, pp. 103382-103382
Open Access | Times Cited: 3
Nan Wang, Bin Shi, Lu Ding, et al.
Redox Biology (2024) Vol. 77, pp. 103382-103382
Open Access | Times Cited: 3
The m6A revolution: transforming tumor immunity and enhancing immunotherapy outcomes
Tongguo Shi, Huan Zhang, Yueqiu Chen
Cell & Bioscience (2025) Vol. 15, Iss. 1
Open Access
Tongguo Shi, Huan Zhang, Yueqiu Chen
Cell & Bioscience (2025) Vol. 15, Iss. 1
Open Access
Xuesong Bai, Jiemin Chen, Wen-Qin Zhang, et al.
Cancer Science (2023) Vol. 114, Iss. 11, pp. 4299-4313
Open Access | Times Cited: 8
Dynamic landscape of m6A modifications and related post-transcriptional events in muscle-invasive bladder cancer
Lili Zhang, Ziwei Chen, Gaoyuan Sun, et al.
Journal of Translational Medicine (2024) Vol. 22, Iss. 1
Open Access | Times Cited: 3
Lili Zhang, Ziwei Chen, Gaoyuan Sun, et al.
Journal of Translational Medicine (2024) Vol. 22, Iss. 1
Open Access | Times Cited: 3
Cigarette smoking combined with genetic variation regulates the m6A methylation of CRNKL1 and is associated with bladder cancer risk
Jialei Yang, Zihan Ji, Fang Gao, et al.
Environmental Toxicology (2024) Vol. 39, Iss. 5, pp. 2782-2793
Closed Access | Times Cited: 2
Jialei Yang, Zihan Ji, Fang Gao, et al.
Environmental Toxicology (2024) Vol. 39, Iss. 5, pp. 2782-2793
Closed Access | Times Cited: 2
Examining the evidence for mutual modulation between m6A modification and circular RNAs: current knowledge and future prospects
Xiaozhu Tang, Mengjie Guo, Yuanjiao Zhang, et al.
Journal of Experimental & Clinical Cancer Research (2024) Vol. 43, Iss. 1
Open Access | Times Cited: 2
Xiaozhu Tang, Mengjie Guo, Yuanjiao Zhang, et al.
Journal of Experimental & Clinical Cancer Research (2024) Vol. 43, Iss. 1
Open Access | Times Cited: 2
Refining the role of N6-methyladenosine in cancer
Jonas Koch, Frank Lyko
Current Opinion in Genetics & Development (2024) Vol. 88, pp. 102242-102242
Open Access | Times Cited: 2
Jonas Koch, Frank Lyko
Current Opinion in Genetics & Development (2024) Vol. 88, pp. 102242-102242
Open Access | Times Cited: 2